Administration of carboline derivatives useful in the treatment of cancer and other diseases

Details for Australian Patent Application No. 2008239598 (hide)

Owner PTC Therapeutics, Inc.

Inventors Davis, Thomas; Cao, Liangxian; Hirawat, Samit; Weetall, Maria L.; Miller, Langdon; Elfring, Gary L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008239598

PCT Pub. Number WO2008/127714

Priority 60/911,612 13.04.07 US

Filing date 12 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/437 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/127714 Priority application(s): WO2008/127714

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

31 May 2012 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2008 Delete all reference to Application No. 2008239598.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239601-Selective androgen receptor modulators for treating diabetes

2008239596-Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer